Summary Rats were prepared surgically so that peripheral intestinal lymph could be collected from them while a syngenieic tumour (the HSN sarcoma) was growing in each major Peyer's patch of the small intestinie. Dendritic lymph cells were isolated from the lymph and injected i.p. into naive, syngeneic rats. Each of the 16 recipients received just under 106 such cells and was challenged 10 days later with a subcutanieous dose of 104 viable HSN cells. Six weeks after this challenge only 7 of the recipients had a tumour anid these \vere small (mean weight 1.8g), while 17 controls (which had each been treated with 106( thoracic duct lymphocytes from the same donors, and given the same challenge) all had large tumours (mean weight 8.8g). The remaining 9 test rats were still free of tumours when they were killed and autopsied 4 months after challelnge.
The occurrence in peripheral lymph of free-floating, nonlymphoid, mononuclear cells with a dendritic morphology was noted first by Morris (1968) ; he described their morphological and ultrastructural features, and emphasised the intimate but transient contacts they made with small lIymphocytes. This fact, together with the relative abundance of dendritic cells in lymph coming from allografts (Pedersen & Morris, 1970) and the necessity of peripheral lymph for the induction of contact sensitivity (Frey & Wenk, 1957) , suggested that these cells might be important in the presentation of antigens, particularly in cell mediated responses (Hall, 1971) . However, decisive experiments were hard to do in the outbred animals in which these phenomena had been demonstrated. Steinman and Cohn (1973) obtained appairently similar cells from the peripheral lymphoid organs of mice, and performed a series of experiments which showed that dendritic cells had important accessory and antigen-presenting functions in viva) and in vitro (Steinman & Nussenzweig, 1980) . The role of such cells in the context of tumour immunology is uncertain.
By excising the mesenteric lymph nodes from experimental animals, and then collecting intestinal lymph sometime later when the lymphatics have repaired themselves, it is possible to obtain peripheral intestinal lymph which, like peripheral lymph from any source (Smith et al., 1970) , contains dendritic cells (Hall cet al., 1977) . This can be done in rats bearing intestinal tumours (Moore et al., 1982; Gyure, et al.. 1985) and this type of preparation has allowed us to collect dendritic cells coming directly from the area of tumour growtll. The ability of such cells to induce anti-tumour immunity after adoptive transfer to naive recipient rats is the subject of the experiments reported below.
Materials and methods

GenCerail exvperimnental clesign
Young (5-6 weeks old) male hooded rats were subjected to mesenetric lymphadenectomy so that 6-8 weeks later, after they had attained adult weight (200-250 g) (Gyure et al., 1985) A nimnals, tliaIours anId surgical procedures Specific pathogen free CBH/Cbi (RT1') rats were taken from our own colony, which is maintained in positive pressure isolators.
The tumour used was in all cases the HSN, a transplantable sarcoma induced originally (1968) with a pellet (s.c.) of 3,4 benzpyrene. This tumour is antigenic and potentially metastatic, and has been the subject of several publications (e.g., Currie & Gage, 1973; Gyure et al., 1980; Eccles, 1982) . Cells from this tumour were first grown in culture 9 years ago and a cloned line, designated HSNtc was established and has formed the basis of much of our work. It has shown little variation in behaviour but as a routine we discard cells that have been passaged in vitro more than 20 times, and start a fresh culture from banked cells. The cells used in the present study had been passaged 7 times in vitro and reacted normally with the appropriate syngeneic, monoclonal antibody (North et al., 1982) . Although The flasks, each of which contained 5 x 101-106 cells in 5 ml medium, were incubated overnight at 37"C in a humidified atmosphere containing 5% CO2.
Assayi ol'f tunoul-growtth
The sites of injection of the challenge dose in the subcuticulum of the rats' flanks were palpated 3 times a week. In control rats an unequivocal nodule of 1-2 mm is usually palpable within 4-5 weeks. The time at which each tumour first became detectable was noted and observation continued. When the tumours in the control rats became very large (up to 15 g) the rats were killed, and their tumours excised, weighed and submitted to histological examination. At the same time any test rats that had palpable tumours were dealt with in the same way. Sixteen weeks after the initial challenge dose of tumour any surviving tumour-free rats were killed and submitted to necropsy.
Cell counits
Counts of the total white cells in lymph and other suspensions of cells were performed by direct microscopy in a Neubauer chamber after appropriate dilution in 1.5% acetic acid.
Differential counts were made by inspecting living cells under a coverslip using a x 100 objective and phase contrast optics. The non-lymphoid mononuclear cells in peripheral lymph are comprised of a spectrum of cells ranging from classical dendritic cells (which tend to be non-adherent and non-phagocytic in in vitro systems) to conventional macrophages which have a less ebullient hyaloplastic membrane, are often replete with ingested detritus, and adhere firmly to glass and plastic. In the present study the incubation step in the cell isolation procedures ensured that Figure 2 .
It can be seen that 5 weeks after the challenge dose of the tumour, all the control rats had unequivocal tumours but more than half (9/16) of the test rats were tumour free. Six weeks after challenge some of the tumours in the control rats were already massive, so all tumour bearing rats, test and control, were killed and their tumours were excised and weighed. The mean weight of the tumours from the 17 control rats were 8.81 g+0.73, and the mean weight of the tumours from the 7 test rats were 1.86g±0.39. The remaining 9 test rats remained tumour free and were killed 16 weeks after the challenge dose; no trace of tumour was found at the injection site, or in any other part of the rats. The rate of growth of the tumours in the control rats was similar to that of historical controls that had received no treatment. Also, an additional 3 control rats, used at the start of the present series, received no treatment before tumour challenge, and all developed large tumours at the same rate as the later, formal controls which received lymphocytes.
The second series of experiments was smaller; a total of 15 rats was used, 5 in each of the test, control and donor Control n=17 .. ......................... groups. Dendritic cells were collected from the lymph of non-tumour bearing donors and incubated overnight with a monolayer of HSNtC cells. The dendritic cells were then decanted and injected i.p. into naive recipients as before. The output of dendritic cells in the lymph of the tumour-free donors was found to be substantially greater than that of their tumour-bearing counterparts, and enabled an average total dose of 3.15 x 106 dendritic cells (range 0.5-6.5 x 106) to be given. In spite of this larger dose, the effects on the subsequent growth of the challenge dose of tumour were less obvious. The times at which the tumours first became detectable did not differ between the tests and controls, and all the rats were killed after six weeks. Nonetheless, the weights of the tumours in the test animals were much less than in the controls, 1.30 g+0.96 vs. 9.30g+2.73.
In both series, histological examination of the tumours confirmed that they had retained their usual characteristics. No (Kelly et al., 1978) , pigs (Mefarlin & Balfour, 1973) and man (Spry et al., 1980) as well as the peripheral lymph of rats. Apparently identical cells can be cultured from human peripheral blood mononuclear cells (Knight et al., 1986) and we have been able to prepare them from the peripheral blood of sheep by similar methods. The exact nature and lineage of dendritic cells is controversial. We believe that they belong to the monocyte-macrophage series because in vivo they phagocytose carbon (Morris, 1968) , red cells (Hall, 1979) and immune complexes (Hall & Robertson, 1984) . Their generally non-adherent and nonphagocytic nature in in vitro systems (which may be caused partly by the anticoagulants necessary for their collection) could be one reason why our attempts to "sensitize' them to the tumour in vitro were only partially successful.
It may be significant that the lymph from tumour bearing rats contained fewer of these cells than that from nontumour bearers. Conceivably, many of the dendritic cells were pre-occupied in the tumour tissue, and were less able to gain entry into the lymph. Previous experiments have shown that rat sarcomata are able to sequester cells of the monocyte-macrophage series and cause a deficit of such cells at other sites (Eccles & Alexander, 1974) .
Clearly, there is much to be learned about these cells but their ability to operate effectively in small numbers is unsettling as well as exciting. If, as Steinman and his colleagues report, such cells are present in most peripheral lymphoid organs, how many of the phenomena of transplantation and tumour biology, previously attributed to lymphocytes prepared from such sources, are really due to the tiny minority of dendritic macrophages that inevitably must have been present?
